You Curing You
By Deborah Rudacille
In November 2008, cancer researcher Drew Pardoll was rushing to catch a flight to Paris, where he would attend a scientific meeting. Pardoll, co-director of the Cancer Immunology and Hematopoiesis Program at Johns Hopkins Medicine, was conducting research on cancer cures through a cutting-edge approach: immunotherapy. Pardoll and his colleagues at Johns Hopkins had developed a vaccine to stimulate the immune system in the fight against malignant cells. The drug was meant to prod the immune system into battling cancer in the same way the body fights viral and bacterial infections—by activating T cells to launch an attack on the invader.